Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Retatrutide (investigational) GLP-1 + GIP + glucagon Retatrutide is still in trials (not approved in the UK)
Postmenopausal women on hormone therapy shed 35% additional weight taking tirzepatide, and the drug reduced body mass and waist circumference in women across all reproductive stages
doi: 10.2741/4708 30 RaisonCLCapuronLMillerAH
These receptors play an important role in regulating sexual desire and arousal
The most important fact is that retatrutide does not currently have a legitimate retail price, insurance price, manufacturer savings-card pathway, pharmacy coupon, or compounded alternative because it remains investigational and is not FDA-approved
US$ 26.82
US$ 21.74
US$ 25.98
US$ 27.65
